Zomedica’s TRUFORMA product had investors dreaming big in 2021.
From under $0.10 to nearly $3, ZOM became a retail darling — especially among pet lovers.
But the hype didn’t match the results, and now it’s back in penny stock territory.
What happened to ZOM — and does it have any bite left?
#ZOM #zomedica #pennystock #stockteller #biotechstocks #petcare #memestocks #VeterinaryTech #financeyoutube #smallcapstocks
コメント